Guardian Express |
Shark Antibodies May Cure Breast Cancer and Aid Survival of the Fittest
Guardian Express Studies have suggested that shark antibodies may help cure breast cancer, and in effect aid Darwin’s theory of survival of the fittest within humanity, like they do in oceanic ecosystems. Sharks are extremely crucial oceanic fish. They are … |
Kids' Liver Transplant Success Varies by Race, Research Shows – HealthDay
|
Kids’ Liver Transplant Success Varies by Race, Research Shows
HealthDay “Further investigation of the reasons for racial and ethnic differences, particularly on a national level, is necessary to identify interventions that may help reduce disparities in pediatric liver transplantation,” she concluded. Over the past 30 … |
Results Presented for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma – Monthly Prescribing Reference
|
Results Presented for Idelalisib in Refractory Indolent Non-Hodgkin’s Lymphoma
Monthly Prescribing Reference Gilead announced results from the Phase 2 study (Study 101-09) evaluating idelalisib, an investigational oral inhibitor of PI3K delta, for the treatment of patients with indolent non-Hodgkin’s lymphoma (iNHL) that is refractory (non-responsive) to … Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent …Business Wire (press release) Gilead Announces Pivotal Phase 2 Results For Idelalisib In Refractory iNHLRTT News |
ImmunoGen, Inc. : Announces Activity Reported with SAR3419 Plus Rituxan In … – 4-traders (press release)
|
ImmunoGen, Inc. : Announces Activity Reported with SAR3419 Plus Rituxan In …
4-traders (press release) … technology, today announced the presentation of clinical findings with SAR3419 (coltuximab ravtansine) used in combination with Rituxan® (rituximab) to treat diffuse large B-cell lymphoma (DLBCL) that previously had been treated with standard … |
Kolltan licenses antibodies from founder – Hartford Business
|
Kolltan licenses antibodies from founder
Hartford Business The so-called anti-KIT receptor tyrosine kinase antibodies were developed in the labs of Joseph Schlessinger at Yale University — a Kolltan founder — and Sachdev Sidu, a geneticist at the University of Toronto and Kolltan adviser. Terms of the deal … |
Obinutuzumab routs rituximab in older chronic lymphocytic leukemia patients – The Oncology Report
This is Local London |
Obinutuzumab routs rituximab in older chronic lymphocytic leukemia patients
The Oncology Report In the CLL11 study of older chronic lymphocytic leukemia (CLL) patients with coexisting medical problems, obinutuzumab (Gazyva) pushed the overall response rate to 78%, compared with 65% with rituximab (Rituxan) (P less than .0001). Both drugs were … Obinutuzumab Tops Rituximab in CLL TrialCancer Network Dr. Goede on Obinutuzumab Versus Rituximab in CLLOncLive New Drug Combo Potentially ‘Practice Changing’ in CLLMedscape Healio –PR Newswire (press release) all 15 news articles » |
NKT Therapeutics' Identifies Novel anti-iNKT Antibodies for Depleting or … – PR Newswire (press release)
|
NKT Therapeutics’ Identifies Novel anti-iNKT Antibodies for Depleting or …
PR Newswire (press release) WALTHAM, Mass., Dec. 9, 2013 /PRNewswire/ — NKT Therapeutics (NKTT) today presented research results with NKT14 and NKT14m, monoclonal antibodies designed to deplete (NKT14) or activate (NKT14m) murine iNKT cells. The results from these … |
Janssen Oncology Data to be Presented at 2013 American Society of … – FiercePharma
|
Janssen Oncology Data to be Presented at 2013 American Society of …
FiercePharma Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin’s lymphoma (NHL). (Abstract 852). |
Kolltan Pharmaceuticals licenses anti-KIT antibodies from University of Toronto – Pharmaceutical Business Review
Kolltan Pharmaceuticals licenses anti-KIT antibodies from University of TorontoPharmaceutical Business ReviewKolltan Pharmaceuticals, a privately held biopharmaceutical company, has signed a licensing agreement with the University of Toronto for anti-K…
Is Uterus Transplant Allowed? – Onislam.net
Is Uterus Transplant Allowed?Onislam.netUterus transplant is permitted according to most scholars and Fiqh councils in many places. This opinion is built on the notion that the uterus is only a container for the baby. The uterus does not transfer any g…